Device for targeted treatment of dermatosis
AssigneeStrata Skin Sciences, Inc.
InventorsJeffrey I. Levatter, David Brooks
Life of this patent
Estimating the term…
Loading patent…
AssigneeStrata Skin Sciences, Inc.
InventorsJeffrey I. Levatter, David Brooks
Estimating the term…
A device for applying targeted phototherapy to an area of diseased skin to place a skin condition into remission and a method of determining a maximum tolerable dose of phototherapy applied to a treatment area of diseased skin to determine an optimum therapeutic dose to quickly place a skin condition into remission. The device can include a housing and an optical matrix arranged within the housing that are attached to a dosimetry device. The optical matrix includes a plurality of at least one of absorptive, reflective and/or partially transmissive regions or arrays of perforations that each permits a different percentage of light to be delivered to an individual's skin. Jigs can be included to arrange a plurality of varying exposures to be placed on the patient's skin. An assessment can then be made as to the maximum tolerable dose of phototherapy that can be applied to the individual's skin in order to place a skin condition into remission.
A dosimetry device that is connectable to a phototherapy apparatus to apply a targeted dose of UVB light to a treatment area of diseased tissue to determine a minimal blistering dose, the dosimetry device comprising:
A method of determining a maximum tolerable dose of phototherapy that is capable of being applied to a treatment area, the method comprising the following steps:
Dependencies are inferred from the claim text.